Shuqi Chen

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA.

Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.

EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA.

Kapa Biosystems, Inc. provides genomic tools. It develops solutions that accelerate genomics research to diagnose, monitor, and treat cancer and complex inherited and infectious diseases. The company was founded by John Foskett, Paul McEwan, Ron McEwan, and Christopher McGuinness in 2006 and is headquartered in Wilmington, MA.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA.

Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA.

Golden Seeds LLC (Golden Seeds) is a venture capital firm founded in 2005 by Stephanie Hanbury-Brown. The firm is headquartered in New York city with an additional offices in Arizona, Atlanta, Boston, Dallas, Houston, New Jersey, New York and Silicon Valley.

New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA.

Management Sciences for Health, Inc. provides healthcare services. The company was founded by Ronald O’Connor in 1971 and is headquartered in Medford, MA.

International Genetic Engineering, Inc. provides engineering services. The private company is based in Santa Monica, CA. The company was founded by Gary L. Wilcox.

Lionheart Ventures Fund invests in profitable middle-market industrial & technology companies located in the US. The fund focuses on companies with an EBITDA of $1 - $10 million, revenues of $5 - $50 million and strong management team. It targets companies operating in the fields of niche industrial manufacturers, engineered product companies, sensors & controls, precision mechanical components, automotive, aerospace/defense, pumps, valves & mixers and other general industrial markets. It provides financing for acquisitions, add-on acquisitions and turnaround situations.

Astia Angels (Astia Angels) is a venture capital subsidiary of Astia, Inc, founded in 2013. The firm is headquartered in San Francisco, California.

Breakout Ventures LP seeks investment opportunities in companies located in the US. The fund targets the companies operating in the fields of technology, biology, materials and energy. It provides financing for early stage capital requirement.

Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA.

Molecular Loop Biosciences, Inc. operates as a biotechnology company. It offers genomics research, clinical, and consumer genetic information. The company was founded by Eric Boyden and Gregory Porreca and is headquartered in Allston, MA.

NanoTomer, Inc. provides bio technology services. The company is headquartered in Boston, MA.

PhageNova Bio, Inc. is a biotechnology company that is developing a modular, bacteriophage-based platform for targeted gene expression in cancer, vaccination, and molecular imaging. PhageNova Bio is based in Scarsdale, NY. The company's lead cancer construct is designed to selectively target tumor-associated blood vessels and tumor cells, resulting in the expression of TNF-?, an anti-tumor agent, specifically and exclusively in tumors. The company has extensively validated tumor targeting and selective gene expression capabilities, and therapeutic efficacy was observed in the absence of dose-limiting toxicity in multiple species and several tumor models. The company was founded by Renata Pasqualini, Wadih Arap, Steven K. Libutti, Juri G. Gelovani, and the CEO is Jason A. Rifkin.

Xylyx Bio, Inc. provides drug discovery and development services for patients. The company is based in Brooklyn, NY. The company was founded in 2016 by Gordana Vunjak-Novakovic, John D. O'Neill. The CEO is Andrea Nye.